CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...